Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E. Kandzari, Denise Reedus, Debbie L. Cohen et al.|The Lancet|2018Cited by 775
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trialRaymond R. Townsend, Felix Mahfoud, David E. Kandzari et al.|The Lancet|2017Cited by 734
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 studyHenry Krum, Murray Esler, Markus P. Schlaich et al.|The Lancet|2013Cited by 622
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialMichael Böhm, Benjamin Blossom, Kazuomi Kario et al.|The Lancet|2020Cited by 586
Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant HypertensionFelix Mahfoud, Michael Böhm, Markus P. Schlaich et al.|Circulation|2011Cited by 569